Gilead voluntarily withdraws urothelial cancer drug in US
(Reuters) – Gilead Sciences (NASDAQ:GILD) said on Friday it was voluntarily withdrawing the U.S. approval for Trodelvy in previously treated patients with
(Reuters) – Gilead Sciences (NASDAQ:GILD) said on Friday it was voluntarily withdrawing the U.S. approval for Trodelvy in previously treated patients with
BERLIN (Reuters) – Adidas (OTC:ADDYY)’ board member for global sales, Arthur Hoeld, will step down from the German sportswear company’s executive board
Investing.com — Jefferies has upgraded Ecolab’s (NYSE:ECL) rating to “buy” from “hold,” reflecting improved expectations for the company’s performance over the coming
Investing.com — Mizuho Securities has adjusted its outlook for auto chip stocks, cutting price targets for key players amid signs of weaker-than-expected
LONDON (Reuters) – Switzerland on Friday said it was “unequivocally” committed to sanctions against Russia after Bern decided not to adopt in
AMSTERDAM/BUCHAREST – Photon Energy N.V. (WSE&PSE: PEN, FSX: A1T9KW) has announced the completion and grid connection of a new 3.2 MWp photovoltaic
ZURICH – Comet, a provider of key technologies for the semiconductor industry, reported a 45.6% increase in net sales for the third
By Allison Lampert and Mike Stone (Reuters) – Spirit AeroSystems (NYSE:SPR) will tell employees on Friday that it will furlough 700 workers for
(Reuters) -CVS Health on Friday named company veteran David Joyner as new CEO, succeeding Karen Lynch who stepped down from the helm
Investing.com — Investors should be positioning for interest rates in the US to be higher in the coming months, according to analysts at